financetom
Business
financetom
/
Business
/
BRIEF-KKR-Led Consortium Starts Sale Process For Around $3.0 Billion Philippines Hospital Business - WSJ
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-KKR-Led Consortium Starts Sale Process For Around $3.0 Billion Philippines Hospital Business - WSJ
Aug 13, 2024 11:03 PM

Aug 14 (Reuters) -

* KKR-LED CONSORTIUM STARTS SALE PROCESS FOR AROUND $3.0

BILLION

PHILIPPINES HOSPITAL BUSINESS - WSJ

* KKR-LED CONSORTIUM STARTS SALE PROCESS FOR AROUND $3.0

BILLION

PHILIPPINES HOSPITAL BUSINESS - WSJ

Source text: [https://tinyurl.com/3mruzee8]

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Is Cipher Mining Stock Up Today?
Why Is Cipher Mining Stock Up Today?
Oct 24, 2025
Shares of Cipher Mining Inc. ( CIFR ) are rose Friday after Jane Street disclosed a 5% passive stake in the company, totaling 19.68M shares. CIFR stock is showing exceptional strength. Check the full analysis here. What Else: Cryptocurrency-linked stocks are experiencing a rally in the cryptocurrency sector driven by a recent rise in Bitcoin, according to Benzinga Pro. Shares...
Core Scientific Announces Fiscal Third Quarter 2025 Results
Core Scientific Announces Fiscal Third Quarter 2025 Results
Oct 24, 2025
AUSTIN, Texas--(BUSINESS WIRE)-- Core Scientific, Inc ( CORZ ). , a leader in digital infrastructure for high-density colocation services and digital asset mining, today announced financial results for the fiscal third quarter of 2025. Fiscal Third Quarter 2025 Financial Results Total revenue was $81.1 million compared to $95.4 million in the third quarter of 2024. Digital asset self-mining revenue was...
Why Is Syndax Stock Down Today?
Why Is Syndax Stock Down Today?
Oct 24, 2025
Shares of Syndax Pharmaceuticals, Inc. ( SNDX ) are trading lower Friday following approval of one of its treatments from the U.S.’s Food and Drug Administration. SNDX shares are retreating from recent levels. Track the action here. What To Know: While the FDA approved the treatment Revuforj for relapsed or refractory acute myeloid leukemia with an NPM1 mutation, the agency...
--Kellanova Keeps Quarterly Dividend at $0.58 a Share, Payable Dec. 15 to Holders of Record Dec. 1
--Kellanova Keeps Quarterly Dividend at $0.58 a Share, Payable Dec. 15 to Holders of Record Dec. 1
Oct 24, 2025
04:01 PM EDT, 10/24/2025 (MT Newswires) -- Price: 83.00, Change: -0.03, Percent Change: -0.04 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved